CLINICAL_TRIALS
trial_result
· 2017-01-20
Clinical Trial Update: A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes [Phase 1]
Summary
This clinical trial update reports a Phase 1 study evaluating NN1250 in young and elderly adults with Type 1 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED